Connect with us

Account

Asymmetrique wins CleanMax Solar’s marketing and branding mandate

Published

on

MUMBAI:  Asymmetrique has won the marketing and brand communications mandate for CleanMax Solar. Asymmetrique will be responsible for a series of activities including brand positioning, digital marketing and lead generation, social media marketing, content creation and marketing, website enhancement and maintenance.

CleanMax Solar is one of the leaders in solar solutions, with the largest installed base of rooftop solar power generation in India. As a first mover in the space, CleanMax Solar enjoys a reputation nationwide of being a solution provider with deep engineering expertise and a no-compromise attitude towards quality.

Speaking on the win, Asymmetrique CEO and MD Nitin Gupta said, “It gives us great pleasure to have acquired the opportunity to create strategic communications for CleanMax Solar’s unique solutions. Our aim is to position the brand as a pioneer in solar power projects and build an effective connect with consumers through focused, cutting edge strategies leveraging our innovative ecosystem.”

Advertisement

 CleanMax Solar MD Kuldeep Jain commented, “We are excited to bring on board Asymmetrique, as our brand solutions partner. With their fresh approach and creative thinking, we feel Asymmetrique is sure to add value and offer advanced business-led solutions”

 

Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Account

BigTrunk Communications wins digital mandate for Soframycin

Published

on

MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.

Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.

“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”

Advertisement

“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”

Continue Reading

Advertisement News18
Advertisement All three Media
Advertisement Whtasapp
Advertisement Year Enders

Copyright © 2026 Indian Television Dot Com PVT LTD

This will close in 10 seconds

×